Clinical Trials Directory

Trials / Completed

CompletedNCT05814562

Cardiovascular Precision Medicine & Remote Intervention

Cardiovascular Precision Medicine & Remote Intervention - Pilot Protocol

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Icahn School of Medicine at Mount Sinai · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This exploratory / proof of concept study aims to evaluate whether it is possible to identify at-risk patients based on EHR review of blood pressure fluctuation over time and cholesterol levels, recruit those patients, and engage them in a remote intervention protocol.

Detailed description

Patients will be screened for participation based on EHR blood pressure measurements. Those who potential meet the prespecified criteria will be approached during a clinic visits about participation in the study. Patients who agree to participate and sign an informed consent will be given an automatic blood pressure monitor and their contact details will be obtained in order to enable administration of the intervention. The intervention's theoretical underpinnings are principles previously identified as promising or helpful in health care management of at-risk patients. The principles are: 1. "Hovering", using a risk marker, to guide an intervention 2. Addressing posttraumatic avoidance as a way to improve adherence, using an imaginal exposure paradigm. 3. Using a remote interventionist via a telemetric interface that involves active, dynamic patient engagement rather than automated processes

Conditions

Interventions

TypeNameDescription
BEHAVIORALRemote InterventionThe study utilizes a tailored telemetric intervention to improve adherence to medications. The telemetric intervention (administered via telephone, or interactive internet chat applications such as Zoom ©, FaceTime ® or Skype ®) will enable experienced therapists to address nonadherence from a remote location, using a structured, tailored approach that accommodates specific patient needs.

Timeline

Start date
2023-04-10
Primary completion
2024-10-25
Completion
2024-10-25
First posted
2023-04-18
Last updated
2024-10-29

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05814562. Inclusion in this directory is not an endorsement.